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The effect of two weeks and twenty-four hours soft contact lens 
cessation times on corneal refractive surgery outcomes 
INTRODUCTION 
 
Soft contact lens (SCL) wear can reduce accuracy of pre-operative 
corneal measurements and outcomes of corneal refractive surgery 
(CRS)1,2. Hypoxia induced by over-wear of SCLs can result in 
reduced corneal metabolism1,2 and alterations to endothelial 
structure resulting in increased light scatter and less light 
transmission3,4. This may affect corneal healing following CRS. The 
time required for resolution of SCL-induced corneal changes can 
vary and can be longer than 2 weeks5,6,7. Despite this, prior to CRS, 
a standard SCL cessation time is advised for all patients. This 
cessation time varies according to governing bodies. United States 
Food and Drug Administration (FDA) guidelines recommend that 
SCL be left out for at least 2 weeks prior to initial consultation8. 
Whereas, the Royal College of Ophthalmologists in the United 
Kingdom recommend removing SCL for 1 day before CRS9. Short 
SCL cessation times prior to CRS may be insufficient for resolution 
of SCL-induced corneal changes.  
 
HYPOTHESIS 
Visual and refractive CRS outcomes would be worse in a SCL group 
compared to a non-contact lens (NCL) group and worse in a SCL 
group who ceased SCL wear for 24 hours when compared to those 
who ceased SCL wear for two weeks prior to examination and 
treatment.  
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METHODS 
 
CRS outcomes of dominant eyes for two groups of previous full-time 
SCL wearing patients were analysed retrospectively; those who 
ceased SCL wear for two weeks (n = 45) and twenty four hours (n = 
49) prior to examination and treatment. In both groups results were 
compared to a NCL control group (2 weeks NCL group n = 45; 24 
hours NCL group n = 49).  
 
LASIK and PRK/LASEK outcomes at one, three and six months 
post-operative visits were assessed for efficacy (unaided distance 
visual acuity (UDVA) and residual refractive error), predictability 
(number of eyes within ± 0.25D and ± 0.50D of desired refractive 
outcome) and safety.  
 
SPSS 22 was used for statistical analysis. Normality for continuous 
data were assessed using the Shapiro-Wilks method. Two-way 
ANOVA parametric testing was used for comparisons of groups. P < 
0.05 was considered statistically significant. 
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CONCLUSION 
 
  
Previous SCL wear did not negatively impact on the outcomes of 
CRS, and SCL cessation times of 2 weeks and 24 hours did not 
result in negative outcomes compared to a NCL control group.  
 
While these results were statistically significant, the number of letters 
difference in UDVA between the SCL and NCL groups was low. 
Therefore one cannot conclude that these results are clinically 
significant, as the standard uncertainty value for visual acuity 
outlined in the International Standards Organisation guidelines is two 
letters of Snellen VA (0.04 LogMAR), with a 95% confidence level of 
4 letters10.  
 
It is likely that the SCL wearers had previously adapted to some 
under-correction of astigmatism in their SCLs and to the increased 
surface irregularity with SCL wear11. Therefore previous SCL wears 
may have coped with the flatter topography profile following CRS 
(Figure 1) and post-operative haze12. However, these results are 
surprising when one considers the effect of the larger image size on 
VA in the NCL group following CRS. One would expect this would 
improve VA in this group compared to the SCL group who were 
accustomed to the larger image size in SCLs, compared to spectacle 
lenses pre-operatively13.  
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Table 1.  
LASIK LASEK/ PRK 
SCL  
(n = 23) 
NCL  
(n = 23) 
Sig 
SCL  
(n = 22) 
NCL  
(n = 22) 
Sig 
2 weeks cessation group 
LogMAR 
BCSVA 
-0.13 ± 0.06 -0.13 ± 0.04 0.19 -0.13 ± 0.05 -0.10 ± 0.07 0.25 
MSE (D) 
 
-3.97 ± 1.84 -2.75 ± 1.66 0.01 -3.98 ± 1.43 -2.95 ± 1.33 0.02 
Age 
(years) 
32.6 ± 7.50 36.0 ± 9.60 0.16 31.4 ± 8.0 37.2 ± 11.0 0.22 
24 hours cessation group 
  
SCL  
(n = 33) 
NCL  
(n = 39) 
Sig 
SCL  
(n = 16) 
NCL  
(n = 10) 
Sig 
LogMAR 
BCSVA 
-0.11 ± 0.02 
  
-0.10 ± 0.03 
  
0.14 
  
-0.10 ± 0.03 
  
-0.10 ± 0.01 
  
0.74 
MSE (D) 
 
-3.78 ± 1.46 -2.57 ± 1.46 0.001 -3.73 ± 1.78 -3.29 ± 1.38 0.51 
Age 
(years) 
30.2 ± 8.25 34.8 ± 8.85 0.05 28.0 ± 5.23 30.9 ± 8.08 0.14 
RESULTS 
 
These findings were reiterated in the 24 hours SCL cessation group 
where the trend towards superior CRS outcomes for efficacy, 
predictability and safety in the SCL group compared to the NCL 
group was continued. UDVA efficacy outcomes following 
LASEK/PRK were significantly better in the SCL group at the six 
month post-operative visit (p = 0.03, Table 3).  
 
 
 
 
 
 
 
 
 
 
 
  
  
LASIK  LASEK/PRK  
SCL  
(n = 17) 
NCL  
(n = 20) 
Sig 
SCL 
(n = 7) 
NCL  
(n = 6) 
Sig 
Efficacy 
UDVA 
(mean ± SD)  
LogMAR  
   
-0.06 ± 0.09 
   
-0.04 ± 0.10 
  
0.53 
   
-0.11 ± 0.03 
   
-0.04 ± 0.07 
   
0.03 
Efficacy 
index 
 
98% 97% 
  
0.74 
100% 97% 
  
0.14 
> 0.3, < 6/12  
n (%) 
0 0 0 0 
< 0.3, > 6/12  
n (%) 
3 (9.1%) 4 (10.3%) 0 2 (20%) 
< 0.0, > 6/6  
n (%) 
2 (6.1%) 5 (12.8%) 0 1 (10%) 
< -0.1, > 6/5  
n (%) 
12 (36.4%) 11 (28.2%) 7 (43.8%) 3 (30%) 
Predictability 
Within ± 0.25D 
 
10 (30.3%) 17 (43.6%) 
 
0.23 
5 (31.3%) 3 (30%) 
 
0.69 
Within ± 0.50D  
 
2 (6.1%) 2 (5.1%) 1 (6.3%) 2 (20%) 
Greater than ± 
0.50D 
5 (15.2%) 1 (2.6%) 1 (6.3%) 1 (10%) 
Safety 
Loss of 2 or 
more lines 
2 (6.1%) 2 (5.1%) 
0.76 
0 0 
0.17 
Loss of 1 line 
  
4 (12.1%) 4 (10.3%) 0 3 (30%) 
Maintain VA or 
loss < 1 line 
9 (27.3%) 10 (25.6%) 5 (31.3%) 3 (30%) 
Gain of 1 line 
1 (3%) 
 
4 (10.3%) 1 (6.3%) 0 
Gain of 2 or 
more lines 
1 (3%) 0 1 (6.3%) 0 
Table 3: Six month post-operative VA and refraction parameters for the 24 hours  
SCL cessation group   
  LASIK LASEK/PRK 
  
SCL 
(n = 19) 
NCL  
(n = 16) 
Sig 
SCL  
(n = 18) 
NCL  
(n = 18) 
Sig 
Efficacy 
UDVA 
(mean ± SD)  
LogMAR  
-0.10 ± 0.10 -0.06 ± 0.07 0.03 -0.10 ± 0.08 -0.04 ± 0.08 0.03 
Efficacy index 97% 98% 
 0.13 
98% 97% 
  0.10 
0.3, < 6/12  
n (%) 
0 0 0 0 
< 0.3, > 6/12  
n (%) 
19 (83%) 16 (70%) 18 (82%) 18 (82%) 
< 0.0, > 6/6 
 n (%) 
17 (74%) 12 (52%) 16 (73%) 15 (68%) 
< -0.1, > 6/5  
n (%) 
14 (61%) 9 (39%) 14 (64%) 6 (27%) 
Predictability 
Within ± 0.25D 14 (61%) 9 (39%) 
 0.92 
8 (36%) 7 (32%) 
 0.71 Within ± 0.50D 18 (78%) 13 (56.5%) 10 (45.5%) 11 (50%) 
Greater than ± 
0.50D 
1 (4%) 3 (13%) 6 (27%) 4 (18%) 
Safety 
Loss 1 line VA 4(21%) 6(37.5%) 
 0.11 
3(17%) 9(50%) 
 0.25 Loss 2 or more 
lines VA 
4(21%) 6(37.5%) 2(11%) 0(0%) 
Table 2: Six month post-operative VA and refraction parameters for the 2 weeks  
SCL cessation group   
Figure1. A: pre-operative topography profile. B: topography profile following  
CRS for myopia.  
Figure 2. Efficacy index  for the 2 weeks SCL cessation group.   
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RESULTS 
 
The demographics of the groups tested can be seen in Table 1. 
There was a trend towards superior CRS outcomes for efficacy, 
predictability and safety in the two weeks SCL cessation group 
compared to NCL group. These results were significantly better for 
LogMAR UDVA in the SCL group and were maintained to the six 
month post-operative visit (LASIK p = 0.03, LASEK/PRK p = 0.03; 
Table 2).  
 
 
 
 
 
 
 
 
 
 
  
